<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35027539</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>13</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>Exosomal circRELL1 serves as a miR-637 sponge to modulate gastric cancer progression via regulating autophagy activation.</ArticleTitle><Pagination><StartPage>56</StartPage><MedlinePgn>56</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">56</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-021-04364-6</ELocationID><Abstract><AbstractText>Circular RNAs (circRNAs) play a vital role in the occurrence and development of tumors, including gastric cancer (GC). However, there are still many circRNAs related to GC whose functions and molecular mechanisms remain undetermined. Herein, we discover circRNA RELL1, which has not been investigated in GC, and it is markedly downregulated in GC tissues, which is related with poor prognosis, more pronounced lymph node metastasis and poor TNM stage. After confirming the circular structure of circRELL1, we found that circRELL1 could block cell proliferation, invasion, migration, and anti-apoptosis in patients with GC by a series of in vivo and in vitro function-related studies. Further mechanism investigation demonstrated that circRELL1 could sponge miR-637 and indirectly unregulated the expression of EPHB3 via modulating autophagy activation in GC. Additionally, circRELL1 can be transmitted by exosomal communication, and exosomal circRELL1 suppressed the malignant behavior of GC in vivo and in vitro. Taken together, this study elucidates the suppressive roles of circRELL1/miR-637/EPHB3 axis through autophagy activation in GC progression, inspiring for further understanding of the underlying molecular mechanisms of GC and providing a promising novel diagnostic circulating biomarker and therapeutic target in GC.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Sang</LastName><ForeName>Huaiming</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-1668-6233</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Weifeng</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-2625-5207</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Peng</LastName><ForeName>Lei</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1206-2327</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wei</LastName><ForeName>Shuchun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hubei Province for Digestive System Disease, Wuhan, Hubei Province, 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Xudong</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-4966-1857</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Keting</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-5073-5983</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jiajia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Meihong</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dang</LastName><ForeName>Yini</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-1006-2155</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. yeani_hi@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Guoxin</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7531-0404</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. guoxinz@njmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C569538">MIRN637 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000079962">RNA, Circular</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079962" MajorTopicYN="N">RNA, Circular</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013274" MajorTopicYN="Y">Stomach Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>14</Day><Hour>5</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35027539</ArticleId><ArticleId IdType="pmc">PMC8758736</ArticleId><ArticleId IdType="doi">10.1038/s41419-021-04364-6</ArticleId><ArticleId IdType="pii">10.1038/s41419-021-04364-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394&#x2013;424. doi: 10.3322/caac.21492.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21492</ArticleId><ArticleId IdType="pubmed">30207593</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">26808342</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5808709</ArticleId><ArticleId IdType="pubmed">29445300</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan P, Yeoh KG. Genetics and molecular pathogenesis of gastric adenocarcinoma. Gastroenterology. 2015;149:1153&#x2013;62..</Citation><ArticleIdList><ArticleId IdType="pubmed">26073375</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Chen Z, Yu S, Nie F, Yan S, Ma P, et al. Long noncoding RNA LINC01234 functions as a competing endogenous RNA to regulate CBFB expression by sponging miR-204-5p in gastric cancer. Clin Cancer Res. 2018;24:2002&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">29386218</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu ZQ, Zhou SL, Li J, Zhou ZJ, Wang PC, Xin HY, et al. Circular RNA sequencing identifies CircASAP1 as a key regulator in hepatocellular carcinoma metastasis. Hepatology. 2020;72:906&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">31838741</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, Li X, Zheng H, Si X, Li B, Wei G, et al. Loss of super-enhancer-regulated circRNA Nfix induces cardiac regeneration after myocardial infarction in adult mice. Circulation. 2019;139:2857&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6629176</ArticleId><ArticleId IdType="pubmed">30947518</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Fang E, Mei H, Chen Y, Li H, Li D, et al. Cis-acting circ-CTNNB1 promotes beta-catenin signaling and cancer progression via DDX3-mediated transactivation of YY1. Cancer Res. 2019;79:557&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">30563889</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q, Zhou B, Cai D, Zong Y, Wu Y, Liu S, et al. Rapid turnover of HBV cccDNA indicated by monitoring emergence and reversion of signature-mutation in treated chronic hepatitis B patients. Hepatology. 2021;73:41&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7898704</ArticleId><ArticleId IdType="pubmed">32189364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23446346</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Z, Cai J, Lin J, Zhou H, Peng J, Liang J, et al. A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer. Mol Cancer. 2020;19:71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7114813</ArticleId><ArticleId IdType="pubmed">32241279</ArticleId></ArticleIdList></Reference><Reference><Citation>Conn SJ, Pillman KA, Toubia J, Conn VM, Salmanidis M, Phillips CA, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160:1125&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">25768908</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Kong R, Wu C, Wang S, Liu Z, Liu S, et al. Circ-MALAT1 functions as both an mRNA translation brake and a microRNA sponge to promote self-renewal of hepatocellular cancer stem cells. Adv Sci. 2020;7:1900949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7029649</ArticleId><ArticleId IdType="pubmed">32099751</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun YM, Wang WT, Zeng ZC, Chen TQ, Han C, Pan Q, et al. circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression. Blood. 2019;134:1533&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6839953</ArticleId><ArticleId IdType="pubmed">31387917</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Z, Yu C, Cui S, Wang H, Jin H, Wang C, et al. circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1. Nat Commun. 2019;10:3200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6642174</ArticleId><ArticleId IdType="pubmed">31324812</ArticleId></ArticleIdList></Reference><Reference><Citation>Sang Y, Chen B, Song X, Li Y, Liang Y, Han D, et al. circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/FOXO3a axis in breast cancer. Mol Ther. 2019;27:1638&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6731174</ArticleId><ArticleId IdType="pubmed">31153828</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell ES, Coelho PP, Park M. LC3C mediates selective autophagy of the MET RTK, inhibiting cancer cell invasion. Autophagy. 2020;16:959&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144864</ArticleId><ArticleId IdType="pubmed">32065021</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J, Chen M, Ai G, Mao W, Li H, Zhou J. Hsa_circ_0023404 enhances cervical cancer metastasis and chemoresistance through VEGFA and autophagy signaling by sponging miR-5047. Biomed. Pharmacother. 2019;115:108957.</Citation><ArticleIdList><ArticleId IdType="pubmed">31082770</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019;88:487&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pubmed">31220978</ArticleId></ArticleIdList></Reference><Reference><Citation>Wortzel I, Dror S, Kenific CM, Lyden D. Exosome-mediated metastasis: communication from a distance. Dev. Cell. 2019;49:347&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">31063754</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G, Zhou W, Pan X, Sun Z, Sun Y, Xu H, et al. Circular RNA profiling reveals exosomal circ_0006156 as a novel biomarker in papillary thyroid cancer. Mol Ther Nucleic Acids. 2020;19:1134&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7016027</ArticleId><ArticleId IdType="pubmed">32059339</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhang H, Yang H, Bai M, Ning T, Deng T, et al. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer. Mol Oncol. 2020;14:539&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7053238</ArticleId><ArticleId IdType="pubmed">31901148</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Quan Y, Fan S, Wang H, Liang J, Huang L, et al. Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression. Cancer Lett. 2020;475:119&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">32014458</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Li Y, Chen B, Zhao J, Yu S, Tang Y, et al. exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes. Nucleic Acids Res. 2018;46:D106&#x2013;D12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5753357</ArticleId><ArticleId IdType="pubmed">30053265</ArticleId></ArticleIdList></Reference><Reference><Citation>Han D, Li J, Wang H, Su X, Hou J, Gu Y, et al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology. 2017;66:1151&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">28520103</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng R, Du M, Wang X, Xu W, Liang J, Wang W, et al. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression. Mol Cancer. 2018;17:143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6169076</ArticleId><ArticleId IdType="pubmed">30285771</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan B, Zhang Y, Liang C, Liu B, Ding F, Wang Y, et al. Stem cell-derived exosomes prevent pyroptosis and repair ischemic muscle injury through a novel exosome/circHIPK3/ FOXO3a pathway. Theranostics. 2020;10:6728&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7295049</ArticleId><ArticleId IdType="pubmed">32550900</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Zhang L, Guo B, Deng J, Wu S, Li F, et al. Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFkappaB/c-Myc signaling in female esophageal carcinoma. Mol Cancer. 2019;18:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6367809</ArticleId><ArticleId IdType="pubmed">30736860</ArticleId></ArticleIdList></Reference><Reference><Citation>White E, Mehnert JM, Chan CS. Autophagy, metabolism, and cancer. Clin Cancer Res. 2015;21:5037&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4646728</ArticleId><ArticleId IdType="pubmed">26567363</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Ma J, Wei J, Meng W, Wang Y, Shi M. lncRNA SNHG11 promotes gastric cancer progression by activating the Wnt/beta-catenin pathway and oncogenic autophagy. Mol Ther. 2021;29:1258&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934455</ArticleId><ArticleId IdType="pubmed">33068778</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou RM, Shi LJ, Shan K, Sun YN, Wang SS, Zhang SJ, et al. Circular RNA-ZBTB44 regulates the development of choroidal neovascularization. Theranostics. 2020;10:3293&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7053208</ArticleId><ArticleId IdType="pubmed">32194869</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Zhang H, Xie F, Tao D, Xiao X, Huang C, et al. Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis. Oncogene. 2020;39:1696&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pubmed">31705065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Chu H, Wen L, Shuai H, Yang D, Wang Y, et al. Competing endogenous RNA network profiling reveals novel host dependency factors required for MERS-CoV propagation. Emerg Microbes Infect. 2020;9:733&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7170352</ArticleId><ArticleId IdType="pubmed">32223537</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu KP, Zhang CL, Ma XL, Hu JP, Cai T, Zhang L. Analyzing the interactions of mRNAs and ncRNAs to predict competing endogenous RNA networks in osteosarcoma chemo-resistance. Mol Ther. 2019;27:518&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6401193</ArticleId><ArticleId IdType="pubmed">30692017</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SH, Jo MJ, Kim BR, Jeong YA, Na YJ, Kim JL, et al. Sonic hedgehog pathway activation is associated with cetuximab resistance and EPHB3 receptor induction in colorectal cancer. Theranostics. 2019;9:2235&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6531304</ArticleId><ArticleId IdType="pubmed">31149041</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu TP, Wang WY, Ma P, Shuai Y, Zhao K, Wang YF, et al. Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer. Oncogene. 2018;37:5020&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">29789713</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SY, Na YJ, Jeong YA, Kim JL, Oh SC, Lee DH. Upregulation of EphB3 in gastric cancer with acquired resistance to a FGFR inhibitor. Int J Biochem Cell Biol. 2018;102:128&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">30044964</ArticleId></ArticleIdList></Reference><Reference><Citation>Blessing AM, Rajapakshe K, Reddy Bollu L, Shi Y, White MA, Pham AH, et al. Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression. Autophagy. 2017;13:506&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5361609</ArticleId><ArticleId IdType="pubmed">27977328</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Li Z, Wang W, Xia Y, He Z, Li B, et al. MIR-1265 regulates cellular proliferation and apoptosis by targeting calcium binding protein 39 in gastric cancer and, thereby, impairing oncogenic autophagy. Cancer Lett. 2019;449:226&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">30779944</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Zhu H, Hu J. CircRAB11FIP1 promoted autophagy flux of ovarian cancer through DSC1 and miR-129. Cell Death Dis. 2021;12:219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7910449</ArticleId><ArticleId IdType="pubmed">33637694</ArticleId></ArticleIdList></Reference><Reference><Citation>Du WW, Yang W, Li X, Awan FM, Yang Z, Fang L, et al. A circular RNA circ-DNMT1 enhances breast cancer progression by activating autophagy. Oncogene. 2018;37:5829&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">29973691</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Mao R, Su W, Yang X, Geng Q, Guo C, et al. Circular RNA circHIPK3 modulates autophagy via MIR124-3p-STAT3-PRKAA/AMPKalpha signaling in STK11 mutant lung cancer. Autophagy. 2020;16:659&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7138221</ArticleId><ArticleId IdType="pubmed">31232177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L, Wang Z, Xie M, Quan Y, Zhu W, Yang F, et al. Silencing of circRACGAP1 sensitizes gastric cancer cells to apatinib via modulating autophagy by targeting miR-3657 and ATG7. Cell Death Dis. 2020;11:169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7058073</ArticleId><ArticleId IdType="pubmed">32139670</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Cui Z, Cheng D, Du Y, Guo X, Gao R, et al. RNF186 regulates EFNB1 (ephrin B1)-EPHB2-induced autophagy in the colonic epithelial cells for the maintenance of intestinal homeostasis. Autophagy. 2020;17:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8525924</ArticleId><ArticleId IdType="pubmed">33280498</ArticleId></ArticleIdList></Reference><Reference><Citation>Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;Chapter 3:22.</Citation><ArticleIdList><ArticleId IdType="pubmed">18228490</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H, Chen Z, Wang S, Zhang R, Qiu W, Zhao L, et al. c-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma. Brain. 2015;138:3654&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">26450587</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Zhang X, Li Z, Wang W, Li B, Huang X, et al. Circular RNA profile identifies circOSBPL10 as an oncogenic factor and prognostic marker in gastric cancer. Oncogene. 2019;38:6985&#x2013;7001.</Citation><ArticleIdList><ArticleId IdType="pubmed">31409903</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartfeld S, Bayram T, van de Wetering M, Huch M, Begthel H, Kujala P, et al. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology. 2015;148:126&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4274199</ArticleId><ArticleId IdType="pubmed">25307862</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>